End Cash: The amount of cash held by the company for the given period.
Oragenics, Inc. (OGEN) had End Cash of $8.40M for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
$-2.29M |
|
-- |
|
-- |
|
$2.50M |
|
$-2.50M |
|
$0.07M |
|
$-2.42M |
|
$-2.42M |
|
$-2.29M |
|
$-2.29M |
|
$-2.29M |
|
$-2.29M |
|
$-2.50M |
|
$-2.50M |
|
2.16M |
|
2.16M |
|
$4.10 |
|
$4.10 |
|
| Balance Sheet Financials | |
$10.07M |
|
-- |
|
-- |
|
$10.07M |
|
$1.79M |
|
-- |
|
-- |
|
$1.79M |
|
$8.28M |
|
$8.28M |
|
$8.28M |
|
4.27M |
|
| Cash Flow Statement Financials | |
$-9.25M |
|
-- |
|
$16.78M |
|
$0.86M |
|
|
End Cash |
$8.40M |
$7.53M |
|
$0.68M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
5.64 |
|
-- |
|
-- |
|
-- |
|
0.03 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-9.25M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-27.61% |
|
-27.61% |
|
-22.71% |
|
-27.61% |
|
$1.94 |
|
$-4.29 |
|
$-4.29 |
|